Bidding 8-10 Dec 2025, price band ₹1008–1062, lot 14 shares.
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 14 Dec | ₹343 | ₹1,405 | 32.25% |
| 13 Dec | ₹343 | ₹1,405 | 32.25% |
| 12 Dec | ₹295 | ₹1,357 | 27.78% |
| 11 Dec | ₹330 | ₹1,392 | 31.07% |
| 10 Dec | ₹291 | ₹1,353 | 27.40% |
| 9 Dec | ₹295 | ₹1,357 | 27.78% |
| 8 Dec | ₹270 | ₹1,332 | 25.42% |
| 7 Dec | ₹262 | ₹1,324 | 24.67% |
| 6 Dec | ₹290 | ₹1,352 | 27.31% |
| 5 Dec | ₹305 | ₹1,367 | 28.72% |
| 4 Dec | ₹365 | ₹1,427 | 34.37% |
| 3 Dec | ₹365 | ₹1,427 | 34.37% |
| 2 Dec | ₹307 | ₹1,369 | 28.91% |
| 1 Dec | ₹0 | ₹1,062 | 0.00% |
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 219.93🔥 | 0.45% |
| bHNI | 246.67🔥 | 0.41% |
| sHNI | 166.46🔥 | 0.60% |
| QIBs | 293.8🔥 | - |
| Retail | 29.73🔥 | 3.4% |
| Employees | 15.35🔥 | 6.5% |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Corona Remedies, founded in 2004 and headquartered in Ahmedabad, Gujarat, is a pharmaceutical company engaged in the research, manufacturing, and marketing of healthcare products. The company offers a range of products across multiple therapeutic areas, including women’s healthcare, cardio-diabetes, pain management, urology, and more. With two manufacturing facilities located in Gujarat and Himachal Pradesh, Corona Remedies has established a significant presence in the Indian pharmaceutical market. The company’s growth strategy includes organic expansion and strategic acquisitions, aiming to enhance its product portfolio and market reach. Corona Remedies continues to focus on delivering quality healthcare solutions to meet the evolving needs of patients.